Scientists at the UCSF Cardiovascular Research Institute have discovered how a change in growth hormone activity in mice leads to fatty liver disease, a condition whose human counterpart is of rising ...

Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents. Background: To evaluate the efficacy and E2,LH,FSH level of goserelin combined with CEF chemotherapy as neoadjuvant therapy in hormone ...

Scientists have revealed deep insights into the role that a little-understood human hormone plays in regulating body weight. Named Growth and Differentiation Factor 15 (GDF15), this hormone is ...

Postmenopausal women have increased risk of non-alcoholic fatty liver disease due to loss of estrogen from metabolic changes. A high-fat diet further exacerbates the disease, which can progress to ...